FR2732346B1 - Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications - Google Patents

Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications

Info

Publication number
FR2732346B1
FR2732346B1 FR9503566A FR9503566A FR2732346B1 FR 2732346 B1 FR2732346 B1 FR 2732346B1 FR 9503566 A FR9503566 A FR 9503566A FR 9503566 A FR9503566 A FR 9503566A FR 2732346 B1 FR2732346 B1 FR 2732346B1
Authority
FR
France
Prior art keywords
mute
proteins
lentivirus
genes
encoded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9503566A
Other languages
English (en)
Other versions
FR2732346A1 (fr
Inventor
Gianfranco Pancino
Pierre Sonigo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9503566A priority Critical patent/FR2732346B1/fr
Priority to PCT/FR1996/000449 priority patent/WO1996030527A1/fr
Priority to JP8529002A priority patent/JPH11503010A/ja
Priority to US08/913,953 priority patent/US5994516A/en
Priority to EP96909201A priority patent/EP0817855A1/fr
Priority to CA002216612A priority patent/CA2216612A1/fr
Publication of FR2732346A1 publication Critical patent/FR2732346A1/fr
Application granted granted Critical
Publication of FR2732346B1 publication Critical patent/FR2732346B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR9503566A 1995-03-27 1995-03-27 Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications Expired - Fee Related FR2732346B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9503566A FR2732346B1 (fr) 1995-03-27 1995-03-27 Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
PCT/FR1996/000449 WO1996030527A1 (fr) 1995-03-27 1996-03-26 Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques et vecteurs d'expression
JP8529002A JPH11503010A (ja) 1995-03-27 1996-03-26 レンチウイルス変異ｅｎｖ遺伝子によりコードされる変異タンパク質、ペプチドフラグメント及び発現ベクター
US08/913,953 US5994516A (en) 1995-03-27 1996-03-26 Mutated proteins encoded by a lentivirus mutated env gene, peptide fragments and expression vectors
EP96909201A EP0817855A1 (fr) 1995-03-27 1996-03-26 Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques et vecteurs d'expression
CA002216612A CA2216612A1 (fr) 1995-03-27 1996-03-26 Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques et vecteurs d'expression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9503566A FR2732346B1 (fr) 1995-03-27 1995-03-27 Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications

Publications (2)

Publication Number Publication Date
FR2732346A1 FR2732346A1 (fr) 1996-10-04
FR2732346B1 true FR2732346B1 (fr) 1997-05-30

Family

ID=9477447

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9503566A Expired - Fee Related FR2732346B1 (fr) 1995-03-27 1995-03-27 Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications

Country Status (6)

Country Link
US (1) US5994516A (fr)
EP (1) EP0817855A1 (fr)
JP (1) JPH11503010A (fr)
CA (1) CA2216612A1 (fr)
FR (1) FR2732346B1 (fr)
WO (1) WO1996030527A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033615A2 (fr) * 1996-03-15 1997-09-18 University Of Southern California Virus de l'arthrite/encephalite caprine assurant une immunoprotection contre l'infection due au vih-1
US6602505B2 (en) 1998-04-30 2003-08-05 University Of Southern California Viral chimeras comprised of CAEV and HIV-1 genetic elements
EP0953574A1 (fr) * 1998-04-30 1999-11-03 Innogenetics N.V. Agent immunodiagnostique pour la détection d'infections par le virus de Maedi-Visna et CAEV
WO2006011919A1 (fr) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Procédé et appareil servant à détecter le virus de l'immunodéficience féline
JP2007505320A (ja) * 2003-09-11 2007-03-08 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
WO2005062053A2 (fr) * 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Procede et dispositif pour detecter le virus d'immunideficience feline
US7348136B2 (en) * 2004-02-19 2008-03-25 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4662988B2 (ja) * 2004-06-30 2011-03-30 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスを検出するための方法および装置
CA2576930C (fr) * 2004-06-30 2011-06-07 Idexx Laboratories, Inc. Procede et appareil servant a detecter le virus de l'immunodeficience feline (vif) comprenant l'utilisation de peptides derives de la region v3 de la proteine env du vif
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
WO2015069469A1 (fr) 2013-11-05 2015-05-14 Clontech Laboratories, Inc. Compositions de transfection sèches et procédés de fabrication et d'utilisation de celles-ci

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910002374B1 (ko) * 1985-04-29 1991-04-20 제네틱 시스템즈 코포레이션 Aids 관련질병의 검출을 위한 합성항원
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3788397T3 (de) * 1986-03-24 2003-11-27 Ortho Pharma Corp Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
DE3886032T2 (de) * 1987-08-21 1994-06-16 Scripps Clinic Res Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
WO1990007119A1 (fr) * 1988-12-20 1990-06-28 Immunodiagnostics, Inc. Peptides synthetiques analogues au vih, leurs compositions et utilisations
JP3356280B2 (ja) * 1991-06-14 2002-12-16 セント・ビンセンツ・インスティテュート・オブ・メディカル・リサーチ・リミテッド 哺乳動物免疫不全ウイルスの検出
ATE278018T1 (de) * 1992-06-16 2004-10-15 Centre Nat Rech Scient Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion
FR2721031B1 (fr) * 1994-06-09 1996-07-26 Centre Nat Rech Scient Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic.

Also Published As

Publication number Publication date
CA2216612A1 (fr) 1996-10-03
FR2732346A1 (fr) 1996-10-04
JPH11503010A (ja) 1999-03-23
US5994516A (en) 1999-11-30
WO1996030527A1 (fr) 1996-10-03
EP0817855A1 (fr) 1998-01-14

Similar Documents

Publication Publication Date Title
ATE237694T1 (de) Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
FR2732346B1 (fr) Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
CA2282497A1 (fr) Bibliotheque d'expression in vitro de proteine ou de peptide
WO2002014525A3 (fr) Utilisation de vecteur d'expression dans une cellule animale
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
ATE312920T1 (de) Dna immunisierung gegen chlamydia infektion
ES2176484T3 (es) Bancos de proteinas/(poli)peptidos.
EP1862472A3 (fr) Protéine de Chlamydia, séquence génétique et utilisations associées
MX9800719A (es) Proteinas de transporte y sus usos.
FR2700169B1 (fr) Nouveaux variants trans-dominants TAT du virus de l'immunodéficience humaine.
WO1994029446A3 (fr) Proteines intracellulaires de liaison (pil) et leurs utilisations
ATE323762T1 (de) Herstellung einer multikombinatorischen bank von antikörpergene-exprimierende vektoren
NO971059L (no) Modifiserte human-C3-proteiner
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DE60044754D1 (de) Trans-lentivirales Vektor System
EP1012603A4 (fr) Fragments fonctionnels de la proteine vpr vih-1 et procedes d'utilisation
EP0911397A4 (fr) Proteines d'antigenes tumoraux, genes derives de ces proteines, et peptides d'antigenes tumoraux
NO991729D0 (no) Anti-p53-enkeltkjede-antistoff-fragmenter og deres anvendelse
RU94046052A (ru) Гены агглютинации, дрожжи
FI951633A (fi) Erittyvien proteiinien lisääntynyt tuotanto eukaryoottisilla yhdistelmäsoluilla
DK0868511T3 (da) Genekspression af utrophin
FR2709132B1 (fr) Fragment d'ADN portant le gène codant pour l'enzyme de fragmentation du N-acétylhéparosane et les séquences adjacentes permettant son expression, enzyme recombinée et son utilisation.
ATE366810T1 (de) Menschliche p51-gene und deren genprodukte
FR2702491B1 (fr) Clonage de gènes codant pour des antigènes d'excrétion-sécrétion P21 et P32 de toxoplasme, préparations de tels antigènes, fragments de ceux-ci et leurs applications.
AU5356596A (en) Dna encoding natural killer lytic associated protein

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20071130